|
|
Previous Article | Table of Contents | Next Article 
Interleukin-10 suppresses human immunodeficiency virus-1 replication in
vitro in cells of the monocyte/macrophage lineage
MW Saville, K Taga, A Foli, S Broder, G Tosato and R Yarchoan
Retroviral Diseases Section, National Cancer Institute, Bethesda, MD 20892.
The cytokine interleukin-10 (IL-10) has been implicated in the pathogenesis
of a number of disease states, including Epstein-Barr virus and human
immunodeficiency virus (HIV-1) infections. In the acquired immunodeficiency
syndrome (AIDS), it has been suggested that IL-10 may have a deleterious
effect by suppressing cell-mediated immunity. However, there are few data
on its direct effects on HIV-1 replication. In the present study, we have
found that recombinant human IL-10 (rhIL-10), present during days 0 through
2, potently inhibits HIV production in elutriated monocyte/macrophage (M/M)
cultures with a 50% inhibitory concentration (IC50) of approximately 0.03
U/mL. This effect did not appear to be caused by toxicity to M/M because
there was no change in cell viability, ability to phagocytose latex beads,
or protein synthesis as measured by [3H]-leucine incorporation, at doses of
rhIL-10 that inhibit viral replication. In addition,
lipopolysaccharide-induced production of IL-1 beta, IL-6, or tumor necrosis
factor-alpha was not affected at these doses, nor were human mononuclear
cell proliferative responses to phytohemagglutinin, OKT3 antibody, or
tetanus toxoid. HIV-1 replication was similarly decreased by rhIL-10 in the
monocytoid line U937 without signs of cellular toxicity. However, these
effects required much higher concentrations of rhIL-10, and viral
production was only partially suppressed. rhIL-10 also slightly inhibited
HIV-induced cytopathicity in ATH-8, a tetanus toxoid-specific, retrovirally
immortalized T-cell line, but had no effect on HIV replication in the H9
and MOLT-4 T cell lines. Thus, rhIL- 10 appears to inhibit HIV replication
predominantly in cells of the M/M lineage. This effect may serve to reduce
viral production in patients with AIDS. However, additional studies will be
needed to more precisely define its physiologic role in this disease.
Volume 83,
Issue 12,
pp. 3591-3599,
06/15/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Fakruddin, R. A. Lempicki, R. J. Gorelick, J. Yang, J. W. Adelsberger, A. J. Garcia-Pineres, L. A. Pinto, H. C. Lane, and T. Imamichi
Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27
Blood,
March 1, 2007;
109(5):
1841 - 1849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ji, G. K. Sahu, V. L. Braciale, and M. W. Cloyd
HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway
Int. Immunol.,
June 1, 2005;
17(6):
729 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zidek, D. Frankova, and A. Holy
Activation by 9-(R)-[2-(Phosphonomethoxy)Propyl]Adenine of Chemokine (RANTES, Macrophage Inflammatory Protein 1alpha ) and Cytokine (Tumor Necrosis Factor Alpha, Interleukin-10 [IL-10], IL-1beta ) Production
Antimicrob. Agents Chemother.,
December 1, 2001;
45(12):
3381 - 3386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ancuta, Y. Bakri, N. Chomont, H. Hocini, D. Gabuzda, and N. Haeffner-Cavaillon
Opposite Effects of IL-10 on the Ability of Dendritic Cells and Macrophages to Replicate Primary CXCR4-Dependent HIV-1 Strains
J. Immunol.,
March 15, 2001;
166(6):
4244 - 4253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pyeon, F. J. Diaz, and G. A. Splitter
Prostaglandin E2 Increases Bovine Leukemia Virus tax and pol mRNA Levels via Cyclooxygenase 2: Regulation by Interleukin-2, Interleukin-10, and Bovine Leukemia Virus
J. Virol.,
June 15, 2000;
74(12):
5740 - 5745.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. B. Stefano, P. Cadet, C. Breton, Y. Goumon, V. Prevot, J. P. Dessaint, J.-C. Beauvillain, A. S. Roumier, I. Welters, and M. Salzet
Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor
Blood,
June 15, 2000;
95(12):
3951 - 3958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Khanna, X.-F. Yu, D. H. Ford, L. Ratner, J. K. Hildreth, and R. B. Markham
Differences Among HIV-1 Variants in Their Ability to Elicit Secretion of TNF-{alpha}
J. Immunol.,
February 1, 2000;
164(3):
1408 - 1415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pyeon and G. A. Splitter
Regulation of Bovine Leukemia Virus tax and pol mRNA Levels by Interleukin-2 and -10
J. Virol.,
October 1, 1999;
73(10):
8427 - 8434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Stefano, V. Prevot, J.-C. Beauvillain, C. Fimiani, I. Welters, P. Cadet, C. Breton, J. Pestel, M. Salzet, and T. V. Bilfinger
Estradiol Coupling to Human Monocyte Nitric Oxide Release Is Dependent on Intracellular Calcium Transients: Evidence for an Estrogen Surface Receptor
J. Immunol.,
October 1, 1999;
163(7):
3758 - 3763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, G. Roderiquez, T. Oravecz, and M. A. Norcross
Cytokine Regulation of Human Immunodeficiency Virus Type 1 Entry and Replication in Human Monocytes/Macrophages through Modulation of CCR5 Expression
J. Virol.,
September 1, 1998;
72(9):
7642 - 7647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Cole, Y. D. Korin, J. L. Fahey, and J. A. Zack
Norepinephrine Accelerates HIV Replication Via Protein Kinase A-Dependent Effects on Cytokine Production
J. Immunol.,
July 15, 1998;
161(2):
610 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. De, C. N.S. Venkateshan, P. Seth, D. Carleton Gajdusek, and C. J. Gibbs Jr
Adenovirus-Mediated Human Immunodeficiency Virus-1 Nef Expression in Human Monocytes/Macrophages and Effect of Nef on Downmodulation of Fcgamma Receptors and Expression of Monokines
Blood,
March 15, 1998;
91(6):
2108 - 2117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sozzani, S. Ghezzi, G. Iannolo, W. Luini, A. Borsatti, N. Polentarutti, A. Sica, M. Locati, C. Mackay, T. N.C. Wells, et al.
Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes
J. Exp. Med.,
February 2, 1998;
187(3):
439 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Brigino, S. Haraguchi, A. Koutsonikolis, G. J. Cianciolo, U. Owens, R. A. Good, and N. K. Day
Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway
PNAS,
April 1, 1997;
94(7):
3178 - 3182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. Wong, P. B. Bongiorno, V. Rettori, S. M. McCann, and J. Licinio
Interleukin (IL) 1beta , IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications
PNAS,
January 7, 1997;
94(1):
227 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Montaner and S Gordon
TH2 downregulation of macrophage HIV-1 replication
Science,
January 27, 1995;
267(5197):
538 - 539.
[PDF]
|
 |
|
|
|